SUBSCRIBE
SUBSCRIBE
News   Policy

Skyepharma PLC in Process of Filing Flutiform in EU

March 25, 2010 | 
1 min read

LONDON, March 25 (Reuters) - British drug delivery specialist SkyePharma (SKP.L) said it was in the process of filing its Flutiform asthma drug for European approval, following recent setbacks in the United States.

Regulatory Europe
MORE ON THIS TOPIC
Creative photo poster picture collage collapsing dollar banknote arm holding cash money bankrupt decrease income funds loss.
Government
FDA Faces ‘Catastrophic Collapse’ as Massive Layoffs Endanger User Fee Program
April 4, 2025
 · 
3 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Approvals
Amgen Wins Expansion for Uplizna as First Drug for IgG4-Related Disease
April 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
April 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Aerial top down view of a large container cargo ship in motion over open ocean with copy space
Government
Drugmakers Ask Trump for Staggered Tariffs as ‘Liberation Day’ Arrives
April 2, 2025
 · 
2 min read
 · 
Tristan Manalac